Maria Primo

Senior Scientist @camenabio. Interested in Molecular Biology | Immunology | Single-cell | Bioinformatics

[Nature Communications @NatureComms]

Here @ClaraAlsinet, @danjgaffney @DamianaAlvarez1 @roserventotormo provide a #SingleCellAtlas of hiPSC-to-myeloid cell differentiation

@OpenTargets @humancellatlas @sangerinstitute

https://t.co/sbP0uKXENg

[Clara Alsinet Armengol @ClaraAlsinet]

1/6
If you are not convinced, yet 😉, of how amazing induced pluripotent stem cells are, have a look at our latest work on human iPSC differentiation to myeloid cells now out in @NatureComms. @sangerinstitute @OpenTargets #singlecell #HumanCellAtlas https://t.co/piAx3vUQT9

[Maria Primo @MariaNascPrimo]

@GerdaKild Congratulations! 🎉😊

[Viki Male @VikiLovesFACS]

#Pregnant people are now a priority group for #CovidVaccination in the UK...

At last!

https://t.co/WZm9ED9MyJ

[Alloy Therapeutics, Inc. @AlloyTx]

We are excited to announce the acquisition of @deepCDRbio and welcoming the team to the Alloy family! The deepCDR bioinformatics and machine learning engine will strengthen antibody discovery and optimization for our community of partners. Learn more: https://t.co/PtM0aN0WRu

[Jeffrey Barrett @jcbarret]

I had a quick look at the three biggest labs supplying @sangerinstitute sequencing, and you can see this leading indicator in the past couple days is going up fast, and the sequences are just about to catch up. (crisis mode means my..ahem..basic figures get into the report)

[Jeffrey Barrett @jcbarret]

Me, in the Observer: Data sharing has a long history in genomics, and exemplary work by scientists in Southern Africa was a huge service to humanity. Let’s make sure to reward them and their fellow citizens. https://t.co/UGcn4T0lVH

[Maria Primo @MariaNascPrimo]

Incredibly proud to finally share our bioRxiv preprint profiling human in vitro myelopoiesis using single-cell RNA-sequencing. Amazing work led @ClaraAlsinet, under the supervision of @danjgaffney and @roserventotormo

[roser @roserventotormo]

Interested in how developmental atlases can dissect in vitro differentiation? Take a look at our latest manuscript led by @ClaraAlsinet profiling human in vitro myelopoiesis, a close collaboration with @danjgaffney team, @DamianaAlvarez1 and our team 👇

https://t.co/5MaYQYmZLh

[Nikos Panousis @npanousis]

Very excited and honored to give an invited talk at #ASHG21 today on our #MacroMap study with @anderson_carl & @danjgaffney.If you are interested to know how genetic variation under stimulation dissects the transcriptional responses of common disease risk alleles, please join us!

[Open Targets @OpenTargets]

CLOSING: Computational Postdoctoral Fellow with the Cvejic and Campbell labs

Analyse new scRNA-Seq/scATAC-Seq data and spatial transcriptomics datasets to understand the molecular properties of immune cells infiltrating tumour sites

Apply by Oct 8
https://t.co/o2n8EDRp66

[Alloy Therapeutics, Inc. @AlloyTx]

Thank you @dslevine for taking the team to speak with us about our biotechnology ecosystem!

[Rasmus O. Bak @rasmus_o_bak]

Vi søger en videnskabelig assistent til at understøtte gruppens forskningsaktiviteter i CRISPR/Cas-baseret genetic engineering. Ansøgningsfrist d. 24. sept.
https://t.co/of7Mt2zAAN

[Professor Chris Whitty @CMO_England]

The great majority of adults have been vaccinated.

Four weeks working on a COVID ward makes stark the reality that the majority of our hospitalised COVID patients are unvaccinated and regret delaying. Some are very sick including young adults.

Please don't delay your vaccine.

[Rasmus O. Bak @rasmus_o_bak]

Retweet: postdoc position available. One week until deadline. Please apply.

[Luke O'Neill @laoneill111]

Power of Pfizer BioNTech vaccine further revealed- it induces a rapid CD8 T cell response boosted hugely after second shot. These cells kill virally-infected cells and variants are less likely to be able to dodge them.

https://t.co/bom0cXOcaq

[Alloy Therapeutics, Inc. @AlloyTx]

We’re proud to expand our growing ecosystem with the official launch of Wheeler Bio—a new biomanufacturing company built to accelerate the translation of therapeutic innovation into clinical impact. Learn more about our collaboration: https://t.co/5fRQ2R6Juy

[Alloy Therapeutics, Inc. @AlloyTx]

We are pleased to support the launch of @vernalbio, which designs and manufactures high purity mRNA for clients of all sizes and stages. Learn more about Vernal and how it supports the growing Alloy ecosystem: #makemedicinetogether https://t.co/qupThWBb2x

[Drug Safety Research @DSRUDrugSafety]

We're now just over halfway in recruiting for our Oxford-AstraZeneca #CovidVaccine study, but we need 10,000 more #volunteers. It's a simple questionnaire format. If you've had your first dose of this vaccine within the last 6 weeks please sign up here. https://t.co/Sskcewf6wa

[Alloy Therapeutics, Inc. @AlloyTx]

We are excited to announce our collaboration with @PyxisOncology to form Kyma Therapeutics – a new joint venture developing immune-modulating antibodies for novel targets in #cancer and #autoimmune diseases. Learn more here: https://t.co/R3F74puWne

[Eric Topol @EricTopol]

You want to really understand how covid drives pathology?
Sequence the cells. Lung. Heart. Kidney. Liver.
New @nature today
https://t.co/ng0uEkoiKg
https://t.co/faTZSEq0jG
@DeloreyTm @broadinstitute @carlygailz
@JCA_Melms @ColumbiaMed @_janabiermann @Columbia
and collaborators